Information on Antiviral Treatment for COVID-19

The use of antiviral medications has the potential to reduce the number of severe COVID-19 cases resulting in hospitalization or death. The Biden administration recently enacted the “Test to Treat'' initiative as a part of the pandemic preparedness plan. The goal of the initiative is to provide free antiviral medication (e.g., Paxlovid) at the time someone tests positive for COVID-19 at participating pharmacy sites. These antivirals are already available through a doctor’s prescription, but this initiative aims to speed up treatment especially for those at high-risk for developing severe COVID-19 (e.g., those with certain chronic health conditions).

What is Paxlovid?

Paxlovid is an antiviral treatment that can be used after infection with the SARS-CoV-2 virus. The drug is not to be used as a preventative measure for COVID-19. Instead, it should be used only after someone contracts COVID-19 because it has the ability to stop the replication of the virus in the body. Paxlovid is most effective when used within three to five days of COVID-19 onset. If utilized properly, it has been shown to reduce the rate of hospitalizations by nearly 90%, and the pill can be taken at home.

Who can take Paxlovid?

Individuals who are 12 and older, have a positive COVID-19 test, and who are at high risk of severe COVID-19 are eligible to receive Paxlovid (e.g., individuals who have certain underlying conditions such as cancer, diabetes and individuals who are 65 years or older).

Where can individuals access Paxlovid?

The Arizona Department of Health Services has created an interactive map on their website that shows the location of available COVID-19 treatments (e.g., antiviral medication and monoclonal antibodies) across the state. Click here to view treatment locations in your area.